-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35

Benzinga·04/30/2026 17:18:04
Listen to the news
Piper Sandler analyst Matt O'Brien reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $28 to $35.